-
Understanding Changes to Medicare Prescription Drug CoverageThe Inflation Reduction Act significantly changes what patients pay out-of-pocket for Medicare Part D prescription drugs in 2024.
sponsored by Triage Cancer
Early findings on therapeutic vaccines suggest they can delay or stop cancer from returning after tumors are surgically removed.
by Kendall K. Morgan
-
Improving Glioblastoma TreatmentPhase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.
by Thomas Celona -
Quality of Life Across the LifespanAs more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.
by Kevin McLaughlin -
Results That MatterCancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons -
Genetic Testing for Women With Breast CancerNew recommendations clarify when women diagnosed with breast cancer should be offered genetic testing for inherited cancer risk.
by Laura Gesualdi-Gilmore -
TIL Therapy Amplifies the Immune System’s Attack on MelanomaThe recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More WomenAn innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
-
From the Bench: Creative Approaches in Cancer ResearchInsects that smell cancer, new CRISPR delivery tools, and a cancer-fighting battery—the AACR's new blog series, From the Bench, highlights creative approaches in cancer research.
The AACR Cancer Progress Report, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.
